Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126545311 | 12654531 | 1 | I | 20160812 | 20160816 | 20160816 | EXP | IE-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00362 | SCIEGEN | 62.00 | YR | F | Y | 0.00000 | 20160816 | OT | IE | IE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126545311 | 12654531 | 1 | PS | Olmesartan Medoxomil tablets 5 mg, 20 mg, 40 mg | OLMESARTAN MEDOXOMIL | 1 | Unknown | UNK | Y | U | 208130 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126545311 | 12654531 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126545311 | 12654531 | HO |
126545311 | 12654531 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126545311 | 12654531 | Abdominal pain | |
126545311 | 12654531 | Decreased appetite | |
126545311 | 12654531 | Dehydration | |
126545311 | 12654531 | Diarrhoea | |
126545311 | 12654531 | Duodenitis | |
126545311 | 12654531 | Hypoalbuminaemia | |
126545311 | 12654531 | Systemic mastocytosis | |
126545311 | 12654531 | Urticaria | |
126545311 | 12654531 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |